Monday, May 4, 2009

Subject: "Reminder-Brasenose Chlamydia Screening Tomorrow"

....thanks, Brasenose! Interestingly enough, Chlamydia is the most common STD in the United States, and is therefore at the forefront (no pun intended) of a bunch of exciting new research.

NEW AND HOT (and lucky for future-Brasenosers): 
Nanoparticle Delivery System Developed to Induce Immunity to STDs. Especially Chlamydia.

Researchers at UCLA have been pioneering a vaccine against Chlamydia using a nanoparticle delivery system, after discovering a connection between vault nanoparticles and mucosal immunity. "Vaults" are "barrel-shaped nanoscale capsules" that are present in the cytoplasm of the cells of all mammals. When they contain immunogenic proteins, these vaults can serve as molecular triggers, or adjuvants, to initiate an immune response even better than that produced by current vaccines for other diseases, since researchers believe these adjuvants can provide immunity at mucosal surfaces while, helpfully, avoiding inflammation that can be destructive. This type of immunization seems to be effective primarily in mucosal infections. 

Article link:


No comments:

Post a Comment